Literature DB >> 2317716

Identifying major concerns of persons with acquired immunodeficiency syndrome: a replication.

M B Longo, J A Spross, A M Locke.   

Abstract

A descriptive study was conducted at two major medical centers in Boston to identify and categorize major concerns of persons with acquired immunodeficiency syndrome. Thirty-four subjects were interviewed using a semistructured instrument, developed by Spross and her colleagues while at the National Institutes of Health. Obtained by referral from nurses caring for them in inpatient and outpatient settings, the majority of subjects were Caucasian, homosexual males from the Boston metropolitan area. The mean age of subjects was 33.6, with 71% less than 35 years old. Subjects reported an average of 3.2 hospitalizations since the AIDS diagnosis had been made; average time since diagnosis was 8 months. Information obtained from subjects included impact of diagnosis, major concerns and sources/types of support perceived to be helpful. Five themes were identified: uncertainty of the future; desire to maintain health; social unacceptability; fatigue; and weight loss.

Entities:  

Mesh:

Year:  1990        PMID: 2317716     DOI: 10.1097/00002800-199000410-00006

Source DB:  PubMed          Journal:  Clin Nurse Spec        ISSN: 0887-6274            Impact factor:   1.067


  3 in total

1.  Effects of two cognitive-behavioral interventions on immunity and symptoms in persons with HIV.

Authors:  R N Lucille Sanzero Eller
Journal:  Ann Behav Med       Date:  1995-12

2.  Describing the health-related quality of life impact of HIV infection: findings from a study using the HIV Overview of Problems--Evaluation System (HOPES).

Authors:  P A Ganz; C A Coscarelli Schag; B Kahn; L Petersen; K Hirji
Journal:  Qual Life Res       Date:  1993-04       Impact factor: 4.147

3.  Assessing the needs and quality of life of patients with HIV infection: development of the HIV Overview of Problems-Evaluation System (HOPES).

Authors:  C A Schag; P A Ganz; B Kahn; L Petersen
Journal:  Qual Life Res       Date:  1992-12       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.